Logo image of CNR

CORE NATURAL RESOURCES INC (CNR) Stock Fundamental Analysis

USA - NYSE:CNR - US2189371006 - Common Stock

72.84 USD
+0.66 (+0.91%)
Last: 9/12/2025, 8:04:00 PM
72.84 USD
0 (0%)
After Hours: 9/12/2025, 8:04:00 PM
Fundamental Rating

5

Taking everything into account, CNR scores 5 out of 10 in our fundamental rating. CNR was compared to 210 industry peers in the Oil, Gas & Consumable Fuels industry. CNR has an average financial health and profitability rating. CNR is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year CNR was profitable.
In the past year CNR had a positive cash flow from operations.
CNR had positive earnings in 4 of the past 5 years.
CNR had a positive operating cash flow in each of the past 5 years.
CNR Yearly Net Income VS EBIT VS OCF VS FCFCNR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

1.2 Ratios

CNR has a worse Return On Assets (0.33%) than 65.71% of its industry peers.
Looking at the Return On Equity, with a value of 0.55%, CNR is doing worse than 64.76% of the companies in the same industry.
The Return On Invested Capital of CNR (1.90%) is worse than 70.95% of its industry peers.
CNR had an Average Return On Invested Capital over the past 3 years of 24.39%. This is above the industry average of 21.91%.
The 3 year average ROIC (24.39%) for CNR is well above the current ROIC(1.90%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 0.33%
ROE 0.55%
ROIC 1.9%
ROA(3y)17.24%
ROA(5y)10.53%
ROE(3y)35.71%
ROE(5y)22.09%
ROIC(3y)24.39%
ROIC(5y)15.83%
CNR Yearly ROA, ROE, ROICCNR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

1.3 Margins

The Profit Margin of CNR (0.63%) is worse than 63.81% of its industry peers.
CNR's Profit Margin has improved in the last couple of years.
CNR's Operating Margin of 3.73% is on the low side compared to the rest of the industry. CNR is outperformed by 69.05% of its industry peers.
In the last couple of years the Operating Margin of CNR has grown nicely.
The Gross Margin of CNR (20.38%) is worse than 66.67% of its industry peers.
In the last couple of years the Gross Margin of CNR has declined.
Industry RankSector Rank
OM 3.73%
PM (TTM) 0.63%
GM 20.38%
OM growth 3Y12.32%
OM growth 5Y2.74%
PM growth 3Y70.14%
PM growth 5Y19.45%
GM growth 3Y-31.09%
GM growth 5Y-21.12%
CNR Yearly Profit, Operating, Gross MarginsCNR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CNR is creating value.
The number of shares outstanding for CNR has been reduced compared to 1 year ago.
CNR has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CNR has an improved debt to assets ratio.
CNR Yearly Shares OutstandingCNR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
CNR Yearly Total Debt VS Total AssetsCNR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

CNR has an Altman-Z score of 1.82. This is not the best score and indicates that CNR is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.82, CNR is in the better half of the industry, outperforming 63.33% of the companies in the same industry.
CNR has a debt to FCF ratio of 2.46. This is a good value and a sign of high solvency as CNR would need 2.46 years to pay back of all of its debts.
CNR's Debt to FCF ratio of 2.46 is fine compared to the rest of the industry. CNR outperforms 79.05% of its industry peers.
CNR has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.09, CNR is doing good in the industry, outperforming 77.62% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 2.46
Altman-Z 1.82
ROIC/WACC0.21
WACC8.96%
CNR Yearly LT Debt VS Equity VS FCFCNR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

CNR has a Current Ratio of 1.78. This is a normal value and indicates that CNR is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.78, CNR is doing good in the industry, outperforming 71.90% of the companies in the same industry.
CNR has a Quick Ratio of 1.25. This is a normal value and indicates that CNR is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of CNR (1.25) is better than 64.29% of its industry peers.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 1.25
CNR Yearly Current Assets VS Current LiabilitesCNR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

7

3. Growth

3.1 Past

CNR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -74.91%.
Measured over the past years, CNR shows a very strong growth in Earnings Per Share. The EPS has been growing by 22.60% on average per year.
Looking at the last year, CNR shows a very strong growth in Revenue. The Revenue has grown by 45.25%.
CNR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.16% yearly.
EPS 1Y (TTM)-74.91%
EPS 3Y93.33%
EPS 5Y22.6%
EPS Q2Q%-135.71%
Revenue 1Y (TTM)45.25%
Revenue growth 3Y19.47%
Revenue growth 5Y9.16%
Sales Q2Q%119.98%

3.2 Future

The Earnings Per Share is expected to grow by 9.84% on average over the next years. This is quite good.
CNR is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 24.91% yearly.
EPS Next Y-110.26%
EPS Next 2Y6.06%
EPS Next 3Y8.3%
EPS Next 5Y9.84%
Revenue Next Year77.87%
Revenue Next 2Y39.37%
Revenue Next 3Y24.91%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CNR Yearly Revenue VS EstimatesCNR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
CNR Yearly EPS VS EstimatesCNR Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5 10 15

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 21.49, the valuation of CNR can be described as rather expensive.
The rest of the industry has a similar Price/Earnings ratio as CNR.
CNR is valuated rather cheaply when we compare the Price/Earnings ratio to 27.30, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 6.74, the valuation of CNR can be described as very cheap.
Based on the Price/Forward Earnings ratio, CNR is valued cheaply inside the industry as 88.57% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.73. CNR is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 21.49
Fwd PE 6.74
CNR Price Earnings VS Forward Price EarningsCNR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CNR is valued a bit cheaper than the industry average as 61.43% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CNR is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 23.59
EV/EBITDA 7.04
CNR Per share dataCNR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.95
EPS Next 2Y6.06%
EPS Next 3Y8.3%

0

5. Dividend

5.1 Amount

With a yearly dividend of 0.76%, CNR is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 6.14, CNR is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.41, CNR's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.76%

5.2 History

CNR has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CNR Yearly Dividends per shareCNR Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

CNR pays out 148.79% of its income as dividend. This is not a sustainable payout ratio.
DP148.79%
EPS Next 2Y6.06%
EPS Next 3Y8.3%
CNR Yearly Income VS Free CF VS DividendCNR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M
CNR Dividend Payout.CNR Dividend Payout, showing the Payout Ratio.CNR Dividend Payout.PayoutRetained Earnings

CORE NATURAL RESOURCES INC

NYSE:CNR (9/12/2025, 8:04:00 PM)

After market: 72.84 0 (0%)

72.84

+0.66 (+0.91%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)11-03 2025-11-03/bmo
Inst Owners91.64%
Inst Owner Change-0.38%
Ins Owners1.83%
Ins Owner Change-5.78%
Market Cap3.75B
Analysts77.5
Price Target96.65 (32.69%)
Short Float %4.87%
Short Ratio2.85
Dividend
Industry RankSector Rank
Dividend Yield 0.76%
Yearly Dividend0.53
Dividend Growth(5Y)N/A
DP148.79%
Div Incr Years0
Div Non Decr Years0
Ex-Date08-29 2025-08-29 (0.1)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-158.97%
Min EPS beat(2)-207.45%
Max EPS beat(2)-110.49%
EPS beat(4)1
Avg EPS beat(4)-94.7%
Min EPS beat(4)-207.45%
Max EPS beat(4)0.73%
EPS beat(8)4
Avg EPS beat(8)-35.57%
EPS beat(12)8
Avg EPS beat(12)-12.67%
EPS beat(16)10
Avg EPS beat(16)-41.07%
Revenue beat(2)2
Avg Revenue beat(2)7.34%
Min Revenue beat(2)2.77%
Max Revenue beat(2)11.91%
Revenue beat(4)3
Avg Revenue beat(4)-1.81%
Min Revenue beat(4)-24.65%
Max Revenue beat(4)11.91%
Revenue beat(8)6
Avg Revenue beat(8)1.77%
Revenue beat(12)10
Avg Revenue beat(12)5.56%
Revenue beat(16)13
Avg Revenue beat(16)9.28%
PT rev (1m)5.28%
PT rev (3m)-2.65%
EPS NQ rev (1m)-106.36%
EPS NQ rev (3m)-105.21%
EPS NY rev (1m)-117.74%
EPS NY rev (3m)-111.09%
Revenue NQ rev (1m)-2.76%
Revenue NQ rev (3m)-9.16%
Revenue NY rev (1m)2.67%
Revenue NY rev (3m)2.65%
Valuation
Industry RankSector Rank
PE 21.49
Fwd PE 6.74
P/S 1.14
P/FCF 23.59
P/OCF 9.54
P/B 1
P/tB 1
EV/EBITDA 7.04
EPS(TTM)3.39
EY4.65%
EPS(NY)10.81
Fwd EY14.84%
FCF(TTM)3.09
FCFY4.24%
OCF(TTM)7.64
OCFY10.49%
SpS63.72
BVpS73.2
TBVpS73.2
PEG (NY)N/A
PEG (5Y)0.95
Profitability
Industry RankSector Rank
ROA 0.33%
ROE 0.55%
ROCE 2.22%
ROIC 1.9%
ROICexc 2.06%
ROICexgc 2.06%
OM 3.73%
PM (TTM) 0.63%
GM 20.38%
FCFM 4.85%
ROA(3y)17.24%
ROA(5y)10.53%
ROE(3y)35.71%
ROE(5y)22.09%
ROIC(3y)24.39%
ROIC(5y)15.83%
ROICexc(3y)28.23%
ROICexc(5y)18.22%
ROICexgc(3y)28.23%
ROICexgc(5y)N/A
ROCE(3y)28.54%
ROCE(5y)18.52%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y35.93%
ROICexc growth 5Y15.67%
OM growth 3Y12.32%
OM growth 5Y2.74%
PM growth 3Y70.14%
PM growth 5Y19.45%
GM growth 3Y-31.09%
GM growth 5Y-21.12%
F-Score6
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 2.46
Debt/EBITDA 0.64
Cap/Depr 58.19%
Cap/Sales 7.14%
Interest Coverage 250
Cash Conversion 74.92%
Profit Quality 770.76%
Current Ratio 1.78
Quick Ratio 1.25
Altman-Z 1.82
F-Score6
WACC8.96%
ROIC/WACC0.21
Cap/Depr(3y)74.91%
Cap/Depr(5y)64.93%
Cap/Sales(3y)7.37%
Cap/Sales(5y)8.18%
Profit Quality(3y)104.03%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-74.91%
EPS 3Y93.33%
EPS 5Y22.6%
EPS Q2Q%-135.71%
EPS Next Y-110.26%
EPS Next 2Y6.06%
EPS Next 3Y8.3%
EPS Next 5Y9.84%
Revenue 1Y (TTM)45.25%
Revenue growth 3Y19.47%
Revenue growth 5Y9.16%
Sales Q2Q%119.98%
Revenue Next Year77.87%
Revenue Next 2Y39.37%
Revenue Next 3Y24.91%
Revenue Next 5YN/A
EBIT growth 1Y-74.63%
EBIT growth 3Y34.19%
EBIT growth 5Y12.15%
EBIT Next Year42.13%
EBIT Next 3Y33.76%
EBIT Next 5Y24.71%
FCF growth 1Y-73.9%
FCF growth 3Y19.97%
FCF growth 5Y31.85%
OCF growth 1Y-49.63%
OCF growth 3Y15.95%
OCF growth 5Y14.26%